Reckitt Benckiser’s Mead Johnson unit and Abbott Laboratories have been ordered to face a new trial in the US over ...

Reckitt Benckiser’s Mead Johnson unit and Abbott Laboratories have been ordered to face a new trial in the US over allegations their premature infant formula can cause a serious gut condition.

Reckitt Benckiser is continuing to assess options for its nutrition operations housing the Mead Johnson infant-formula business. After describing nutrition as “non-core” in July as part of a ...

The stable outlook reflects Moody’s base case expectations that Reckitt’s gross debt/EBITDA leverage will stay at or below 2.5x, and that the company’s competitive position will continue to support ...

In March 2024, a U.S. court in Illinois awarded $60 million in damages to a mother of a baby that died from necrotizing enterocolitis (NEC) after being fed Enfamil Premature 24, with the judge ruling ...

Back in October, a jury found North Chicago-based Abbott and Reckitt’s formula subsidiary Mead Johnson not responsible for a baby developing necrotizing enterocolitis, or NEC, from their ...

(Reckitt) and its subsidiaries, Mead Johnson Nutrition Co., Reckitt Benckiser Treasury Services Plc and Reckitt Benckiser Treasury Services (Nederland) B.V. Simultaneously, the outlook for these ...

“There may also be disappointment that Reckitt didn’t have anything more definitive to say about an exit from its Mead Johnson infant formula arm. The $18 billion capture of this business in ...

Missouri 22nd Judicial Circuit Court Judge Michael Noble granted the plaintiff's motion for a new trial on Thursday, citing ...